Cargando…

A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

BACKGROUND: This study examined the efficacy and safety of N-acetylcysteine (NAC) augmentation for treating irritability in children and adolescents with autism spectrum disorders (ASD). METHOD: Forty children and adolescents met diagnostic criteria for ASD according to DSM-IV. They were randomly al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghanizadeh, Ahmad, Moghimi-Sarani, Ebrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737121/ https://www.ncbi.nlm.nih.gov/pubmed/23886027 http://dx.doi.org/10.1186/1471-244X-13-196

Ejemplares similares

Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2017)

Evidence based administration of risperidone and paliperidone for the treating conduct disorder
por: Ghanizadeh, Ahmad
Publicado: (2013)

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
por: Ahmadi, Jamshid, et al.
Publicado: (2019)

Efficacy of Oral Mucoadhesive N-Acetylcysteine Tablets in Treatment of Recurrent Aphthous Stomatitis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial
por: Eslami, Gohar, et al.
Publicado: (2023)

N-acetylcysteine for treatment of autism, a case report
por: Ghanizadeh, Ahmad, et al.
Publicado: (2012)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder
por: Desousa, Avinash
Publicado: (2010)

Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2014)

Prophylaxis of contrast-induced nephropathy in patients with impaired renal function: double-blind comparison of acetylcysteine, theophylline, acetylcysteine + theophylline and placebo
por: Huber, W, et al.
Publicado: (2005)

Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial
por: Mortazavi, Mehran, et al.
Publicado: (2015)

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
por: Conus, Philippe, et al.
Publicado: (2018)

Risperidone Versus Risperidone Plus Sodium Valproate for Treatment of Bipolar Disorders: A Randomized, Double-Blind Clinical-Trial
por: Moosavi, S. Mohammad, et al.
Publicado: (2014)

Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arabzadeh, Somaye, et al.
Publicado: (2018)

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
por: Rossell, Susan L., et al.
Publicado: (2016)

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
por: Neill, Erica, et al.
Publicado: (2022)

Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive‐compulsive disorder in patients with bipolar disorder: Double‐blind, randomized clinical trial
por: Khorshidian, Faezeh, et al.
Publicado: (2023)

Clinical Approach to Motor Stereotypies in Autistic Children
por: Ghanizadeh, Ahmad
Publicado: (2010)

The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial
por: Padoei, Fateme, et al.
Publicado: (2022)

Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2017)

Risperidone-induced priapism in an autistic child: a case report
por: Aabbassi, Bouchra, et al.
Publicado: (2016)

Effect of Methylphenidate and Folic Acid on ADHD Symptoms and Quality of Life and Aggression: A Randomized Double Blind Placebo Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2013)

The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial
por: Schulte, MHJ, et al.
Publicado: (2017)

Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)

N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
por: Klauser, Paul, et al.
Publicado: (2018)

The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial
por: Liao, Yue, et al.
Publicado: (2022)

A Randomised, Double Blind Trial of N-Acetylcysteine for Hearing Protection during Stapes Surgery
por: Bagger-Sjöbäck, Dan, et al.
Publicado: (2015)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder
por: Wink, Logan K., et al.
Publicado: (2016)

N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial
por: Fraga, Cassiana Mazon, et al.
Publicado: (2016)

N-acetylcysteine as an add-on to Directly Observed Therapy Short-I therapy in fresh pulmonary tuberculosis patients: A randomized, placebo-controlled, double-blinded study
por: Mahakalkar, Sunil M., et al.
Publicado: (2017)

Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial
por: Sahraian, Ali, et al.
Publicado: (2015)

A quality assessment of clinical practice guidelines with recommendations for family involvement in the care of individuals diagnosed with schizophrenia, bipolar mood disorder, and major depressive disorder: Critical appraisal utilizing AGREE II
por: Dehbozorgi, Raziye, et al.
Publicado: (2023)

Effects of Risperidone on Core Symptoms of Autistic Disorder Based on Childhood Autism Rating Scale: An Open Label Study
por: Ghaeli, Padideh, et al.
Publicado: (2014)

Schizoaffective Disorder That Is Induced By Electrical Voltage That Is Treated with Risperidone
por: Fadhilah, Ihsan, et al.
Publicado: (2019)

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
por: Ellegaard, Pernille Kempel, et al.
Publicado: (2018)

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
por: Zhang, Hongyan, et al.
Publicado: (2011)

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
por: Maier, Alice, et al.
Publicado: (2020)

N-acetylcysteine in the Treatment of Internet Gaming Disorder
por: Singh, Aakanksha, et al.
Publicado: (2022)

Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis
por: Mano-Sousa, Brayan Jonas, et al.
Publicado: (2021)

Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome?
por: Nikolaou, Kalliopi N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3bl872noja8fkaq578a8eh0b1u